WHO ICTRP trial
MEK114375: A Rollover Study to Provide Continued Treatment with GSK1120212 to…
NL-OMON38447 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON38447 |
|---|---|
| Public title | MEK114375: A Rollover Study to Provide Continued Treatment with GSK1120212 to Subjects with Solid Tumors or Leukemia |
| Scientific title | MEK114375: A Rollover Study to Provide Continued Treatment with GSK1120212 to Subjects with Solid Tumors or Leukemia - MEK114375 |
| Primary sponsor | GlaxoSmithKline |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 2 |
| Countries | Argentina;Australia;Austria;Belgium;Canada;France;Germany;Greece;Hungary;Italy;Korea (the Republic of);Netherlands ;New Zealand;Poland;Russian Federation ;Spain;Sweden;Switzerland;Taiwan (Province of… |
| Conditions | non-small cell lung cancer; lung cancer;10029107;non-small cell lung cancer; lung cancer |
| Interventions | Treatment with trametinib. ;leukemia;solid;trametinib;tumor |
| Registration date | Jul 4, 2013 |
| Target size | 1 |
| Secondary IDs | 2010-023015-33;clinicaltrials.gov; registratienummer n.n.b.;NL43632.042.13 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: